Evidence map›Paper›PMID 36510584›Full record

ArticleComputational and mathematical methods in medicine2022

Lizhu Chen, Jie Lin, Bin Lan, Jiani Xiong, Yaoming Wen, Yu Chen, Chuan-Ben Chen

Open access · hybridAbstract read
In one paragraph

Article in Computational and mathematical methods in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Lizhu ChenDepartment of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China.ORCID https://orcid.org/0000-0002-9881-2976
Jie LinDepartments of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China.ORCID https://orcid.org/0000-0003-0338-6861
Bin LanCancer Bio-immunotherapy Center, Clinical Oncology School of Fujian Medical University and Fujian Cancer Hospital, Fuzhou, Fujian Province, China.ORCID https://orcid.org/0000-0002-2951-8087
Jiani XiongDepartment of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China.ORCID https://orcid.org/0000-0001-6237-7514
Yaoming WenFujian Institute of Microbiology, Fuzhou, Fujian Province, China.ORCID https://orcid.org/0000-0002-6200-9292
Yu ChenDepartment of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian Province, China.ORCID https://orcid.org/0000-0003-4293-1324
Chuan-Ben ChenCancer Bio-immunotherapy Center, Clinical Oncology School of Fujian Medical University and Fujian Cancer Hospital, Fuzhou, Fujian Province, China.ORCID https://orcid.org/0000-0002-5994-8897
Fujian Medical University · CNFujian Institute of Microbiology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Globally, head and neck squamous cell carcinoma (HNSCC) is a common malignant tumor with high morbidity and mortality. Hence, it is important to find effective biomarkers for the diagnosis and prediction of the prognosis of patients with HNSCC. Methods: The Cancer Genome Atlas (TCGA) dataset, Genotype-Tissue Expression (GTEx) dataset, the Clinical Proteomic Tumor Analysis Consortium (CPTAC) dataset, and The Human Protein Atlas (THPA) website were used to assess HNSCC expressions in tumor and nontumor tissues. Then, we further conducted immunohistochemistry experiment as internal cohort to validate the same results. The Cox regression analysis, Kaplan-Meier analysis, and nomograms were performed to find the predictive prognostic value of Results: In different datasets, Conclusion: Our study explored the impact of

Indexed as

Head and Neck NeoplasmsProteomicsBiomarkers, TumorCytokinesHumansPrognosisSquamous Cell Carcinoma of Head and NeckTumor MicroenvironmentBiomarkers, TumorCytokinesFAM3D protein, human

Identifiers

PMID36510584
PMCPMC9741545
OpenAlexW4311248603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.